Literature DB >> 3581898

Pathophysiology and treatment of Lassa fever.

S P Fisher-Hoch, J B McCormick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3581898     DOI： 10.1007/978-3-642-71726-0_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  9 in total

1.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

2.  Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Authors:  Nadezhda E Yun; Alexey V Seregin; David H Walker; Vsevolod L Popov; Aida G Walker; Jeanon N Smith; Milagros Miller; Juan C de la Torre; Jennifer K Smith; Viktoriya Borisevich; Joseph N Fair; Nadia Wauquier; Donald S Grant; Bayon Bockarie; Dennis Bente; Slobodan Paessler
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

3.  Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.

Authors:  Juan D Rodas; Igor S Lukashevich; Juan C Zapata; Cristiana Cairo; Ilia Tikhonov; Mahmoud Djavani; C David Pauza; Maria S Salvato
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

4.  Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.

Authors:  Igor S Lukashevich; Ilia Tikhonov; Juan D Rodas; Juan C Zapata; Yida Yang; Mahmoud Djavani; Maria S Salvato
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.

Authors:  Trevor V Gale; Timothy M Horton; Donald S Grant; Robert F Garry
Journal:  PLoS Negl Trop Dis       Date:  2017-09-18

Review 6.  Improving the Breadth of the Host's Immune Response to Lassa Virus.

Authors:  Juan Carlos Zapata; Sandra Medina-Moreno; Camila Guzmán-Cardozo; Maria S Salvato
Journal:  Pathogens       Date:  2018-10-28

7.  An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.

Authors:  Juan C Zapata; Bhawna Poonia; Joseph Bryant; Harry Davis; Eugene Ateh; Lanea George; Oswald Crasta; Yan Zhang; Tom Slezak; Crystal Jaing; C David Pauza; Marco Goicochea; Dmitry Moshkoff; Igor S Lukashevich; Maria S Salvato
Journal:  Virol J       Date:  2013-02-12       Impact factor: 4.099

Review 8.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

9.  Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.

Authors:  Juan Carlos Zapata; Ricardo Carrion; Jean L Patterson; Oswald Crasta; Yan Zhang; Sachin Mani; Marti Jett; Bhawna Poonia; Mahmoud Djavani; David M White; Igor S Lukashevich; Maria S Salvato
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.